Identification of regulatory elements directing miR-23a-miR-27a-miR-24-2 transcriptional regulation in response to muscle hypertrophic stimuli

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 9, 2014, Pages 885-897

  Hernandez Torres, Francisco ^a   Aranega, Amelia E ^a   Franco, Diego ^a  

^a UNIVERSITY OF JAÉN   (Spain)

Author keywords

MicroRNA; MiR 23; MiR 24; MiR 27; Muscle; Transcriptional regulation

Indexed keywords

ANGIOTENSIN II; MICRORNA; MICRORNA 23A; MICRORNA 24 2; MICRORNA 27A; NORADRENALIN; UNCLASSIFIED DRUG;

3T3 CELL LINE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE; GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; HEART MUSCLE; HEART MUSCLE CELL; MODULATION; MOUSE; MUSCLE HYPERTROPHY; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SRF GENE; TRANSCRIPTION REGULATION;

MICRORNA; MIR-23; MIR-24; MIR-27; MUSCLE; TRANSCRIPTIONAL REGULATION;

3T3 CELLS; ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; GENE EXPRESSION REGULATION; GENES, REGULATOR; HYPERTROPHY; MICE; MICRORNAS; MUSCLE, SKELETAL; MYOCYTES, CARDIAC; NOREPINEPHRINE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84907659979     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.07.009     Document Type: Article

References (73)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Pawlicki J.M., Steitz J.A. Nuclear networking fashions pre-messenger RNA and primary microRNA transcripts for function. Trends Cell Biol. 2010, 20:52-61.
3. Callis T.E., Chen J.-F., Wang D.-Z. MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol. 2007, 26:219-225.
4. Callis T.E., Wang D.Z. Taking microRNAs to heart. Trends Mol. Med. 2008, 14:254-260.
5. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
6. Chinchilla A., Lozano E., Daimi H., Esteban F.J., Crist C., Aranega A.E., Franco D. MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression. Cardiovasc. Res. 2011, 89:98-108.
7. Crist C.G., Montarras D., Pallafacchina G., Rocancourt D., Cumano A., Conway S.J., Buckingham M. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13383-13387.
8. Lozano-Velasco E., Contreras A., Crist C., Hernández-Torres F., Franco D., Aránega A.E. Pitx2c modulates Pax3+/Pax7+ cell populations and regulates Pax3 expression by repressing miR27 expression during myogenesis. Dev. Biol. 2011, 357:165-178.
9. Lin Z., Murtaza I., Wang K., Jiao J., Gao J., Li P.F. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12103-12108.
10. Wang K., Lin Z.-Q., Long B., Li J.-H., Zhou J., Li P.-F. Cardiac hypertrophy is positively regulated by microRNA miR-23a. J. Biol. Chem. 2012, 287:589-599.
11. Wada S., Kato Y., Okutsu M., Miyaki S., Suzuki K., Yan Z., Schiaffino S., Asahara H., Ushida T., Akimoto T. Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J. Biol. Chem. 2011, 286:38456-38465.
12. Nishi H., Ono K., Horie T., Nagao K., Kinoshita M., Kuwabara Y., Watanabe S., Takaya T., Tamaki Y., Takanabe-Mori R., Wada H., Hasegawa K., Iwanaga Y., Kawamura T., Kita T., Kimura T. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes. Mol. Cell. Biol. 2011, 31:744-755.
13. Huang Z., Chen X., Yu B., He J., Chen D. MicroRNA-27a promotes myoblast proliferation by targeting myostatin. Biochem. Biophys. Res. Commun. 2012, 423(2):265-269.
14. Li R.-C., Tao J., Guo Y.-B., Wu H.-D., Liu R.-F., Bai Y., Lv Z.-Z., Luo G.-Z., Li L.-L., Wang M., Yang H.-Q., Gao W., Han Q.-D., Zhang Y.-Y., Wang X.-J., Xu M., Wang S.-Q. In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice. Circ. Res. 2013, 112:601-605.
15. Lee Y., Kim M., Han J., Yeom K.-H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
16. Hernández-Torres F., Rastrojo A., Aguado B. Intron retention and transcript chimerism conserved across mammals: Ly6g5b and Csnk2b-Ly6g5b as examples. BMC Genomics 2013, 14:199.
17. Verzi M.P., Agarwal P., Brown C., McCulley D.J., Schwarz J.J., Black B.L. The transcription factor MEF2C is required for craniofacial development. Dev. Cell 2007, 12:645-652.
18. Wang D.Z., Valdez M.R., McAnally J., Richardson J., Olson E.N. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development 2001, 128:4623-4633.
19. Gurha P., Abreu-Goodger C., Wang T., Ramirez M.O., Drumond A.L., van Dongen S., Chen Y., Bartonicek N., Enright A.J., Lee B., Kelm R.J., Reddy A.K., Taffet G.E., Bradley A., Wehrens X.H., Entman M.L., Rodriguez A. Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 2012, 125:2751-2761.
20. Wu W., Huang X., Cheng J., Li Z., de Folter S., Huang Z., Jiang X., Pang H., Tao S. Conservation and evolution in and among SRF- and MEF2-type MADS domains and their binding sites. Mol. Cell. Evol. 2010, 28:501-511.
21. Daubas P., Klarsfeld A., Garner I., Pinset C., Cox R., Buckingham M. Functional activity of the two promoters of the myosin alkali light chain gene in primary muscle cell cultures: comparison with other muscle gene promoters and other culture systems. Nucleic Acids Res. 1988, 16:1251-1271.
22. Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 1963, 17:299-313.
23. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., Izzo N.J. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2979-2984.
24. Garrido-Godino A.I., García-López M.C., Navarro F. Correct assembly of RNA polymerase II depends on the foot domain and is required for multiple steps of transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 2013, 33:3611-3626.
25. Lozano-Velasco E., Chinchilla A., Martínez-Fernández S., Hernández-Torres F., Navarro F., Lyons G.E., Franco D., Aránega A.E. Pitx2c modulates cardiac-specific transcription factors networks in differentiating cardiomyocytes from murine embryonic stem cells. Cells Tissues Organs (Print) 2011, 194:349-362.
26. Hescheler J., Fleischmann B.K., Lentini S., Maltsev V.A., Rohwedel J., Wobus A.M., Addicks K. Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. Cardiovasc. Res. 1997, 36:149-162.
27. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
28. Livak K.J., Schmittgen T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the method. Methods 2001, 25(4):402-408. (ISSN 1046-2023).
29. Wang J., Xu R., Lin F., Zhang S., Zhang G., Hu S., Zheng Z. MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart. Cardiology 2009, 113:81-88.
30. Han M., Toli J., Abdellatif M. MicroRNAs in the cardiovascular system. Curr. Opin. Cardiol. 2011, 26:181-189.
31. Cao L., Kong L.-P., Yu Z.-B., Han S.-P., Bai Y.-F., Zhu J., Hu X., Zhu C., Zhu S., Guo X.-R. MicroRNA expression profiling of the developing mouse heart. Int. J. Mol. Med. 2012, 30:1095-1104.
32. Ovcharenko I., Loots G.G., Nobrega M.A., Hardison R.C., Miller W., Stubbs L. Evolution and functional classification of vertebrate gene deserts. Genome Res. 2005, 15:137-145.
33. Voronova A., Al Madhoun A., Fischer A., Shelton M., Karamboulas C., Skerjanc I.S. Gli2 and MEF2C activate each other's expression and function synergistically during cardiomyogenesis in vitro. Nucleic Acids Res. 2012, 40:3329-3347.
34. Ji Z.-X., Du C., Wu G.-S., Li S.-Y., An G.-S., Yang Y.-X., Jia R., Jia H.-T., Ni J.-H. Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C. Mol. Genet. Genomics 2009, 281:1-10.
35. Bhattacharya S., Macdonald S.T., Farthing C.R. Molecular mechanisms controlling the coupled development of myocardium and coronary vasculature. Clin. Sci. 2006, 111:35-46.
36. Suzuki H., Suzuki A., Maekawa Y., Shiraishi S., Tamura T.-A. Interplay between two myogenesis-related proteins: TBP-interacting protein 120B and MyoD. Gene 2012, 504(2):213-219.
37. Mastroyiannopoulos N.P., Nicolaou P., Anayasa M., Uney J.B., Phylactou L.A. Down-regulation of myogenin can reverse terminal muscle cell differentiation. PLoS One 2012, 7:e29896.
38. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
39. Jentzsch C., Leierseder S., Loyer X., Flohrschütz I., Sassi Y., Hartmann D., Thum T., Laggerbauer B., Engelhardt S. A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J. Mol. Cell. Cardiol. 2012, 52:13-20.
40. Kolodziejczyk S.M., Wang L., Balazsi K., DeRepentigny Y., Kothary R., Megeney L.A. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr. Biol. 1999, 9:1203-1206.
41. Zhang X., Azhar G., Chai J., Sheridan P., Nagano K., Brown T., Yang J., Khrapko K., Borras A.M., Lawitts J., Misra R.P., Wei J.Y. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H1782-H1792.
42. Kuwahara K., Teg Pipes G.C., McAnally J., Richardson J.A., Hill J.A., Bassel-Duby R., Olson E.N. Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J. Clin. Invest. 2007, 117:1324-1334.
43. Zanou N., Gailly P. Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways. Cell. Mol. Life Sci. 2013, 70(21):4117-4130.
44. A.KF Pathophysiologic Role of the Renin-Angiotensin-Aldosterone and Sympathetic Nervous Systems in Heart Failure 2004.
45. Lunde I.G., Kvaløy H., Austbø B., Christensen G., Carlson C.R. Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes. J. Appl. Physiol. 2011, 111:1278-1289.
46. Mascareno E., Dhar M., Siddiqui M.A. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5590-5594.
47. Marrero M., Schieffer B., Paxton W., Heerdt L. Direct Stimulation of Jak/STAT Pathway by the Angiotensin II AT1 Receptor 1995.
48. Bhat G.J., Thekkumkara T.J., Thomas W.G., Conrad K.M., Baker K.M. Angiotensin II stimulates cis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. J. Biol. Chem. 1994, 269:31443-31449.
49. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 2010, 38:323-332.
50. Davis B.N., Hata A. Regulation of microRNA biogenesis: a myriad of mechanisms. Cell Commun. Signal. 2009, 7:18.
51. Corcoran D.L., Pandit K.V., Gordon B., Bhattacharjee A., Kaminski N., Benos P.V. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One 2009, 4:e5279.
52. Monteys A.M., Spengler R.M., Wan J., Tecedor L., Lennox K.A., Xing Y., Davidson B.L. Structure and activity of putative intronic miRNA promoters. RNA 2010, 16:495-505.
53. Mahony S., Corcoran D.L., Feingold E., Benos P.V. Regulatory conservation of protein coding and microRNA genes in vertebrates: lessons from the opossum genome. Genome Biol. 2007, 8:R84.
54. Huang S., He X., Ding J., Liang L., Zhao Y., Zhang Z., Yao X., Pan Z., Zhang P., Li J., Wan D., Gu J. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int. J. Cancer 2008, 123:972-978.
55. Gao P., Tchernyshyov I., Chang T.-C., Lee Y.-S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T., Dang C.V. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
56. Chhabra R., Adlakha Y.K., Hariharan M., Scaria V., Saini N. Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells. PLoS One 2009, 4:e5848.
57. Pandya K., Smithies O. β-MyHC and cardiac hypertrophy: size does matter. Circ. Res. 2011, 109:609-610.
58. Jeong M.H., Lee J.S., Kim D.H., Park W.J., Yang D.K. Identification of novel microRNAs negatively regulating cardiac hypertrophy. Biochem. Biophys. Res. Commun. 2012, 428:191-196.
59. Yang J., Nie Y., Wang F., Hou J., Cong X., Hu S., Chen X. Reciprocal regulation ofmiR-23a and lysophosphatidic acid receptor signaling in cardiomyocytehypertrophy. Biochim Biophys Acta 2013, 1831(8):1386-1394.
60. Wang L., Quian L. miR-24 regulates intrinsic apoptosis pathway in mouse cardiomyocytes. PLoS One 2014, 9:e85389.
61. Fiedler J., Jazbutyte V., Kirchmaier B.C., Gupta S.K., Lorenzen J., Hartmann D., Galuppo P., Kneitz S., Pena J.T., Sohn-Lee C., Loyer X., Suotschek J., Brand T., Tuschi T., Heineke J., Martin U., Shulte-Merker S., Ertl G., Engelhardt S., Bauersachs J., Thum T. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2012, 124:720-730.
62. Quian L., van Laake L.W., Huang Y., Liu S., Wendland M.F., Srivastava D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 2011, 208:549-560.
63. Li R.C., Tao J., Guo Y.B., Wu H.D., Liu R.F., Bai Y., Lv Z.Z., Luo G.Z., Li L.L., Wang M., Wang H.Q., Gao W., Han Q.D., Zhang Y.Y., Wang X.J., Xu M., Wang S.Q. In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice. Circ. Res. 2013, 112:601-605.
64. Hudson M.B., Woodworth-Hobbs M.E., Zheng B., Rahnert J.A., Blount M.A., Gooch J.L., Searles C.D., Price S.R. miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export. Am. J. Physiol. Cell Physiol. 2014, 306:C551-C558.
65. Chen X., Huang Z., Chen D., Yang T., Liu G. Role of miRNA-27a in myoblast differentiation. Cell Biol. Int. 2014, 38:266-271.
66. Sun Q., Zhang Y., Yang G., Chen X., Zhang Y., Cao G., Wang J., Sun Y., Zhang P., Fan M., Shao N., Yang X. Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res. 2008, 36:2690-2699.
67. Kalsotra A., Singh R.K., Gurha P., Ward A.J., Creighton C.J., Cooper T.A. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression. Cell Rep. 2014, 6:336-345.
68. Li Q., Guo J., Lin X., Yang X., Ma Y., Fan G.C., Chang J. An intragenic SRF-dependent regulatory motif directs cardiac-specific microRNA-1-1/133a-2 expression. PLoS One 2013, 8:e75470.
69. Zheng G., Tao Y., Yu W., Schwartz R.J. Brief report: SRF-dependent miR-201 silences the sonic hedgehog signaling during cardiopoesis. Stem Cells 2013, 31:2279-2285.
70. Piriyapongsa J., Jordan I.K., Conley A.B., Ronan T., Smalheiser N.R. Transcription factor binding sites are highly enriched within microRNA precursor sequences. Biol. Direct 2011, 6:61.
71. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
72. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 2010, 39:373-384.
73. Blahna M.T., Hata A. Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Curr. Opin. Cell Biol. 2013, 25:233-240.